natgillin/translations-raw huggingface dataset:
Diarrhea, nausea and vomiting 
Driska, navzea in bruhanje
Tetracycline compounds Potentiation of the blood-glucose lowering 
Tetraciklinijeve spojine Potenciranje zniževanja ravni glukoze v krvi
No interaction studies have been performed for the two oral suspensions of glibenclamide (0.6 mg/mL and 6 mg/mL). 
Za peroralni suspenziji glibenklamida (0,6 mg/ml in 6 mg/ml) niso bile izvedene študije o medsebojnem delovanju.
Talk to your doctor before your child is given AMGLIDIA. 
Pred dajanjem zdravila AMGLIDIA otroku se posvetujte z zdravnikom.
AMGLIDIA therapy should be initiated at 0.2 mg/kg per day in two divided doses before feeding (including bottle feeding) and increased by 0.2 mg/kg/day until insulin independence is achieved. 
Zdravljenje z zdravilom AMGLIDIA je treba začeti z odmerkom 0,2 mg/kg na dan v dveh ločenih odmerkih pred hranjenjem (vključno s hranjenjem po steklenički), potem pa ga povečati na
The bottle must be closed after each use and stored for a maximum of 30 days. 
Steklenico po vsaki uporabi zaprite in jo hranite največ 30 dni.
The 5 mL syringe is thick and long and graduated in steps of 0.1 mL. 
1 ml brizga je tanka in kratka ter graduirana po 0,05 ml. 5 ml brizga je debela in dolga ter graduirana po 0,1 ml.
Incorrect dosage of coumarin derivatives administered 
Nepravilni dani odmerki derivatov kumarina
In a phase II, single-centre, prospective, open-label, non-randomised study, acceptability, efficiency and tolerance of the switch from crushed tablets to Amglidia suspension were measured. 
V enocentrični, prospektivni, odprti, nerandomizirani študiji druge faze so se merile sprejemljivost,
Nausea, vomiting, flushing, dizziness, headache, chest and abdominal discomfort, and general hangover-like symptoms among others have occurred following the concomitant use of alcohol and glibenclamide. 
Pri sočasni uporabi alkohola in glibenklamida so se pojavili slabost, bruhanje, rdečica, omotičnost, glavobol, neprijeten občutek v prsnem košu in trebuhu ter splošni simptomi, podobni simptomom po prekrokani noči.
After opening, keep the bottle tightly closed after each use and stored for a maximum of 30 days. 
Po odprtju steklenico po vsaki uporabi dobro zaprite in jo hranite največ 30 dni.
Salicylates (such as aminosalicylic acid, para-aminosalicylic acid used for tuberculosis) 
Salicilati (kot sta aminosalicilna kislina in paraaminosalicilna kislina), ki se uporabljajo za zdravljenje tuberkuloze
Open the bottle by unscrewing the child-resistant closure while pressing downwards. 
Odprite steklenico tako, da odvijete za otroke varno zapiralo, medtem ko ga potiskate navzdol.
Glibenclamide suspension therapy should be initiated by a physician experienced in the treatment of patients with very early onset diabetes. 
4.2 Odmerjanje in način uporabe Zdravljenje s suspenzijo glibenklamida mora začeti zdravnik, ki ima izkušnje z zdravljenjem bolnikov s sladkorno boleznijo, ki se pojavi v zelo zgodnjem obdobju.
MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS BOTTLE 
PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA MANJŠIH STIČNIH OVOJNINAH
This medicine is a ready-for-use oral suspension to be given with a marked oral syringe. 
To zdravilo je peroralna suspenzija, pripravljena-za-uporabo, ki se daje z označeno peroralno brizgo.
AMGLIDIA is indicated for the treatment of neonatal diabetes in newborns, infants and children. 
Zdravilo AMGLIDIA je indicirano za zdravljenje sladkorne bolezni pri novorojenčkih, dojenčkih in otrocih.
Increased blood-glucose levels 
Povišane ravni glukoze v krvi
AMGLIDIA should not be used in patients with insulin-dependent type 1 diabetes mellitus with evidence of auto-immune destruction of beta cells. 
Zdravilo AMGLIDIA se ne sme uporabljati pri bolnikih z od insulina odvisno sladkorno boleznijo tipa
• Choice of the syringe to be used: After the total daily dose and the strength to be used have been defined, the frequency of the daily administration should be pointed out and the corresponding volume per administration should be calculated. 
Po določitvi skupnega dnevnega odmerka in jakosti, ki jo je treba uporabiti, je treba izpostaviti pogostost vsakodnevnega dajanja zdravila ter izračunati ustrezen volumen zdravila za dajanje.
Close the bottle by tightening the screw cap well on top of the adaptor. 
Zaprite steklenico, tako da dobro privijete pokrovček z navojem na vrh nastavka.
Blood and lymphatic system disorders Neutropenia Metabolism and nutrition disorders Hypoglycaemia Gastrointestinal disorders 
Bolezni krvi in limfatičnega sistema Nevtropenija Presnovne in prehranske motnje
Your child's blood sugar levels may become too low (hypoglycaemia) after taking AMGLIDIA. 
Po zaužitju zdravila AMGLIDIA lahko ravni sladkorja v krvi pri vašem otroku postanejo prenizke (hipoglikemija).
Dose adjustment is required in patients with mild to moderate renal impairment (refer to section 4.2). 
Pri bolnikih z blago do zmerno okvaro ledvic je treba odmerek prilagoditi (glejte poglavje 4.2).
Blood sugar levels too low Incorrect dosage of coumarin derivatives administered 
Prenizke ravni sladkorja v krvi Nepravilni dani odmerki derivatov kumarina
Miconazole used to treat fungal infection Blood sugar levels too low Nicotinic acid (in high doses) used to decrease high levels of cholesterol and triglycerides which are fat-like substances in the blood 
Nikotinska kislina (v velikih odmerkih), ki se uporablja za zniževanje visokih ravni holesterola in trigliceridov, ki so maščobam podobne snovi v krvi
Biguanides (such as metformin) used to treat diabetes mellitus 
Bigvanidi (kot je merformin), ki se uporabljajo za zdravljenje sladkorne bolezni
You must talk to a doctor if your child does not feel better or if he/she feels worse after a few days. 
Če se znaki bolezni vašega otroka poslabšajo ali ne izboljšajo v nekaj dneh, se posvetujte z zdravnikom.
Disulfiram-like reactions have occurred very rarely following the concomitant use of alcohol and glibenclamide. 
Zelo redko se po sočasnem uživanju alkohola in glibenklamida pojavijo reakcije, ki so podobne reakcijam, ki jih sproži disulfram.
Weakening of the blood-glucose-lowering effect and, thus, raised blood-glucose levels may occur when taking other medicinal products. 
V primeru jemanja drugih zdravil lahko učinek zniževanja ravni glukoze v krvi oslabi in s tem se zviša raven glukoze v krvi.
Hypoglycaemia can occur under treatment with hypoglycaemic sulphonamides. 
Pri zdravljenju s hipoglikemičnimi sulfonamidi se lahko pojavi hipoglikemija.
- Other laboratory blood tests changes: increased levels of the white blood cells called eosinophils 
- začasne motnje vida; - druge spremembe, ki jih pokažejo laboratorijski krvni testi: povišane ravni belih krvničk,
Replace the screw cap on the bottle with the adaptor. 
Pokrovček z navojem ponovno namestite na steklenico z nastavkom.
Blood sugar levels too low Incorrect control of plasma sugar low blood sugar levels may be hidden 
Prenizke ravni sladkorja v krvi Nepravilen nadzor sladkorja v plazmi; nizke ravni sladkorja v krvi so lahko prikrite
Holding the bottle the right way up, insert the syringe firmly into the adaptor fitted to the bottle (figure 2). 
Držite steklenico pokonci in brizgo čvrsto vstavite v nastavek, nameščen na steklenico
Prescription instructions 
Navodila za predpisovanje zdravila
Insert the adaptor firmly into the bottle while holding the bottle the right way up. 
Nastavek čvrsto vstavite v steklenico, pri tem jo držite pokonci.
Each mL contains 6 mg glibenclamide. 
En ml vsebuje 6 mg glibenklamida.
Tooth discoloration 
Bruhanje Dispepsija
Always use this medicine exactly as your doctor or pharmacist has told you. 
Pri jemanju tega zdravila natančno upoštevajte navodila zdravnika ali farmacevta.
Too low blood sugar (hypoglycaemia) (very common: may affect more than 1 in 10 people) If you take AMGLIDIA, you are at risk of getting too low blood sugar (hypoglycaemia). 
Prenizka raven sladkorja v krvi (hipoglikemija) (zelo pogosta: lahko se pojavi pri več kot 1 od 10 bolnikov)
How to store AMGLIDIA 
Shranjevanje zdravila AMGLIDIA
Gastro intestinal disorders (very common: may affect more than 1 in 10 people): - Diarrhea - Abdominal (belly) pain - Vomiting - Stomach ache (Dyspepsia) 
Želodčno-črevesne motnje (zelo pogoste: lahko se pojavijo pri več kot 1 od 10 bolnikov): - driska
You must check your child's blood sugar (capillary blood sugar) and give AMGLIDIA as soon as you realise you have forgotten to use it. 
Preveriti morate raven sladkorja v krvi svojega otroka (sladkor v kapilarni krvi) in dati zdravilo
Start AMGLIDIA at a dose of 0.2 mg/kg/day, in two administration. 
AMGLIDIA za 0,2 mg/kg/dan.
Each mL contains 0.6 mg glibenclamide. 
En ml vsebuje 0,6 mg glibenklamida.
See your doctor, nurse or your hospital pharmacist immediately. 
Če ste otroku dali večji odmerek zdravila AMGLIDIA, kot bi smeli Nemudoma obiščite zdravnika, medicinsko sestro ali farmacevta v bolnišnici.
Dose adjustment is required in patients with mild to moderate hepatic impairment. 
Pri bolnikih z blago do zmerno okvaro jeter je treba odmerek prilagoditi.
In case of major vomiting, ketonemia and ketonuria should be closely monitored by the treating doctor. 
V primeru hudega bruhanja mora lečeči zdravnik otroka skrbno spremljati glede ketonemije in ketonurije.
AMGLIDIA is indicated for the treatment of neonatal diabetes mellitus, for use in newborns, infants and children. 
Zdravilo AMGLIDIA je indicirano za zdravljenje sladkorne bolezni, za uporabo pri novorojenčkih,
Tell the doctor if your child is pale, sweating, has irregular heart rhythm or seems disoriented, confused or unresponsive. 
Če se pri vašem otroku pojavijo bledica, potenje ali neenakomerno bitje srca ali se zdi, da je otrok dezorientiran, zmeden ali neodziven, o tem obvestite zdravnika.
Package leaflet: Information for the user AMGLIDIA 6 mg/mL oral suspension 
Navodilo za uporabo: informacije za uporabnika AMGLIDIA 6 mg/ml peroralna suspenzija glibenklamid
(hypereosinophilia), mild to severe decrease in blood components called platelets 
imenovanih eozinofilci (hipereozinofilija), blago do močno zmanjšanje števila komponent krvi,
On Day 2, if administered sub-cutaneously, basal insulin can be removed. 
Če se bazalni insulin daje subkutano, se lahko drugi dan ukine.
Blood sugar levels too low Increased blood sugar levels Incorrect control of plasma sugar 
Prenizke ravni sladkorja v krvi Povišane ravni sladkorja v krvi Nepravilen nadzor sladkorja v plazmi
Package leaflet: Information for the user AMGLIDIA 0.6 mg/mL oral suspension 
Navodilo za uporabo: informacije za uporabnika AMGLIDIA 0,6 mg/ml peroralna suspenzija glibenklamid
Dose adjustment is required in patients with mild to moderate renal impairment. 
Pri bolnikih z blago do zmerno okvaro ledvic je treba odmerek prilagoditi.
AMGLIDIA 0.6 mg/mL oral suspension AMGLIDIA 6 mg/mL oral suspension 
AMGLIDIA 0,6 mg/ml peroralna suspenzija AMGLIDIA 6 mg/ml peroralna suspenzija
Retighten the screw cap to push the adaptor well into the bottle. 
Pokrovček z navojem ponovno privijte, da nastavek dobro potisnete v steklenico.
Weakening of the blood-glucoselowering effect 
Slabitev učinka zniževanja ravni glukoze v krvi
AMGLIDIA 6 mg/mL oral suspension Each mL contains 6 mg glibenclamide. 
AMGLIDIA 6 mg/ml peroralna suspenzija 1 ml vsebuje 6 mg glibenklamida.
Blood sugar levels too low Incorrect control of plasma sugar 
Prenizke ravni sladkorja v krvi Nepravilen nadzor sladkorja v plazmi
AMGLIDIA 0.6 mg/mL oral suspension Each mL contains 0.6 mg glibenclamide. 
AMGLIDIA 0,6 mg/ml peroralna suspenzija 1 ml vsebuje 0,6 mg glibenklamida.
Transfer to sulfonylureas occurred in childhood with a median [IQR] at transfer of 4.8 years [1.7 - 11.4 years]. 
starosti 4,8 leta (1,7-11,4 leta).
Disopyramide used to treat an irregularity in the heartbeat 
Dizopiramid, ki se uporablja za zdravljenje neenakomernega srčnega utripa
Colesevelam 
Holesevelam
Patients should be closely monitored by their treating physician during the titration phase. 
V fazi titracije mora lečeči zdravnik skrbno spremljati bolnike.
Please read the posology and method of administration in the SmPC attached to this prescriber's guide. 
Preberite informacije o odmerjanju in načinu uporabe v povzetku glavnih značilnosti zdravila,
The signs of too low blood sugar may include: - shaking, sweating, feeling very anxious or confused, fast heart beat 
- tresenje, potenje, močan občutek strahu ali zmedenost, hiter srčni utrip
Blood sugar levels too low 
Prenizke ravni sladkorja v krvi
AMGLIDIA 0.6 mg/mL oral suspension AMGLIDIA 6 mg/mL oral suspension glibenclamide 
AMGLIDIA 0,6 mg/ml peroralna suspenzija AMGLIDIA 6 mg/ml peroralna suspenzija glibenklamid peroralna uporaba
- Transient visual disturbances. 
- Navodilo shranite.
The medicine is administered as a ready-for-use oral suspension to be given using a specific marked syringe. 
pripravljena za uporabo, ki se daje z uporabo posebne označene brizge.
Potentiation of the blood-glucose lowering 
Potenciranje zniževanja ravni glukoze v krvi
Depending on the volume calculated per administration: If the volume per administration is 1mL or below, the 1mL syringe should be prescribed; If the volume per administration is more than 1mL, the 5mL syringe should be prescribed. 
če je volumen zdravila za dajanje manjši kot 1 ml, je treba predpisati 1 ml brizgo;
• The Amglidia 0.6 mg/mL strength should not be used for posology higher than 0.6 mg/kg/day to limit the exposure to the sodium benzoate excipient. 
0,6 mg/kg/dan, da se omeji izpostavljenost natrijevemu benzoatu kot pomožni snovi.
Biguanides 
Dizopiramid
- Increase in sensitivity of the skin to sunlight - Transient visual disturbances. 
- večja občutljivost kože na svetlobo; - začasne motnje vida; - druge spremembe, ki jih pokažejo laboratorijski krvni testi: povišane ravni belih krvničk,
MAO inhibitors 
Zaviralci MAO
Glibenclamide has been shown to be effective in patients with mutations in the genes coding for the βcell ATP-sensitive potassium channel and chromosome 6q24-related transient neonatal diabetes mellitus. 
Glibenklamid se je izkazal za učinkovitega pri bolnikih z mutacijami genov, ki kodirajo od ATP
CONDITIONS DE PRESCRIPTION ET DE DÉLIVRANCE 
OZNAČEVANJE IN NAVODILO ZA UPORABO
INDICATIONS D'UTILISATION 
B. NAVODILO ZA UPORABO
If the blood-glucose level exceeds 
Če je raven glukoze v kapilarni krvi
Dose omission 
SPROŠČANJE SERIJ
Maximum recommended posology (expressed as mg/kg/day) where the AMGLIDIA 0.6 mg/mL strength can be used 
Največji priporočeni odmerek (izražen v mg/kg/dan),
If you give more AMGLIDIA to your child than you should 
če opazite, da je vaš otrok bolj bled kot ponavadi.
Active substance 
SEZNAM POMOŽNIH SNOVI
ONCE DAILY 
ENKRAT NA DAN
Children and adolescents Don't give this medicine to children or adolescents below the age of 18 years. 
Otroci in mladostniki Tega zdravila ne smete dajati otrokom ali mladostnikom, mlajšim od 18 let.
contact your doctor as soon as possible. 
se čim prej posvetujte z zdravnikom.
Not for acute use 
Ni za akutno uporabo
DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 15 November 2017 
DATUM PRIDOBITVE/PODALJŠANJA DOVOLJENJA ZA PROMET Z ZDRAVILOM Datum prve odobritve: 15. november 2017
The pre-specified non-inferiority margin was 50 mL. 
Vnaprej določena meja neinferiornosti je bila 50 mL.
Further management should be clinically indicated or as recommended by the national poisons centre, where available. 
Nadaljnje ukrepanje mora potekati, kot je klinično indicirano ali kot priporoča nacionalni Center za zastrupitve, kjer je ta na voljo.
• weakening of the bones, leading to fractures. 
• oslabitev kosti, ki povzroča zlome.
Where adverse reaction frequencies differed between studies, the higher frequency is reported below. 
Kjer so se pogostnosti neželenih učinkov med študijami razlikovale, je spodaj navedena večja pogostnost.
For further instructions for use and handling, see section 4.2. 
Za dodatna navodila za uporabo in ravnanje glejte poglavje 4.2.
Hold this breath in for as long as possible (at least 3-4 seconds). 
Dih zadržite, kolikor je mogoče dolgo (vsaj 3 do 4
Don't stop unless your doctor advises you to, even if you feel better, as your symptoms may get worse. 
Ne nehajte ga uporabljati, če vam tega ne svetuje zdravnik, tudi če se počutite bolje, ker se vam simptomi lahko poslabšajo.
Glaxo Wellcome Production Zone Industrielle No.2, 23 Rue Lavoisier, 27000 Evreux, France 
Glaxo Wellcome Production Zone Industrielle No. 2, 23. rue Lavoisier, 27000 Evreux, Francija
• painful and frequent urination (may be signs of a urinary tract infection) 
• boleče in pogosto uriniranje (lahko je znak okužbe sečil),
When used regularly, it can help to control your breathing difficulties and reduce the effects of COPD on your everyday life. 
Če ga uporabljate redno, vam lahko pomaga obvladati težko dihanje in zmanjšati vpliv KOPB na vaše vsakdanje življenje.
The decrease in serum potassium is usually transient, not requiring supplementation. 
Znižanje kalija v serumu je po navadi prehodno in ne zahteva dodajanja.
It is very important that you use Trelegy Ellipta every day, as instructed by your doctor. 
Zelo pomembno je, da zdravilo Trelegy Ellipta uporabljate vsak dan, kot vam je naročil zdravnik.
At this dose, no effects on systemic exposure were observed. 
Ob tem odmerku niso opazili učinkov na sistemsko izpostavljenost.
Contents of the pack and other information Step-by-step instructions 
Vsebina pakiranja in dodatne informacije Navodila po korakih
Use of Rescue Medication 
Uporaba rešilnega zdravila
Other side effects have occurred but their exact frequency is not known (frequency cannot be estimated from the available data): 
Drugi neželeni učinki so se pojavili, a njihova natančna pogostnost ni znana (pogostnoti ni mogoče oceniti na podlagi podatkov, ki so na voljo): • zamegljen vid.
Increasing use of short-acting bronchodilators to relieve symptoms may indicate deterioration of disease control. 
Naraščanje uporabe kratkodelujočih bronhodilatatorjev za olajšanje simptomov je lahko znak, da se urejenost bolezni slabša.
The first time you use Trelegy Ellipta you do not need to check that the inhaler is working properly; it contains previously measured doses and is ready to use straight away. 
Ko prvič uporabite zdravilo Trelegy Ellipta, vam ni treba preverjati, ali inhalator deluje pravilno; inhalator vsebuje predhodno odmerjene odmerke in je pripravljen za takojšnjo uporabo.
If possible, show them the inhaler, the package or this leaflet. 
Če je mogoče, mu pokažite inhalator, pakiranje zdravila ali to navodilo za uporabo.
If a dose is missed the next dose should be taken at the usual time the next day. 
Če bolnik pozabi uporabiti odmerek, mora naslednji odmerek uporabiti naslednji dan ob običajnem času.
See section 4 ‘Possible side effects' for information on symptoms to look out for while you are using this medicine. 
Glejte poglavje 4, "Možni neželeni učinki", za informacije o simptomih, na katere morate biti pozorni med uporabo tega zdravila.
These may affect up to 1 in 10 people: 
Pojavijo se lahko pri največ 1 od 10 bolnikov:
COPD is a longterm condition characterised by breathing difficulties that slowly get worse. 
KOPB je dolgotrajna bolezen, za katero so značilne težave z dihanjem, ki se polagoma slabšajo.
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before using this medicine. 
Če vam je zdravnik povedal, da imate intoleranco za nekatere sladkorje, se z njim posvetujte, preden uporabite to zdravilo.
Health-Related Quality of Life 
Zdravstvena kakovost življenja
The frequency of adverse reactions is defined using the following convention: very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to <1/1,000); very rare (<1/10,000) and not known (cannot be estimated from available data). 
Pogostnost neželenih učinkov je opredeljena upoštevaje naslednji dogovor: zelo pogosti (≥ 1/10), pogosti (≥ 1/100 do < 1/10), občasni (≥ 1/1.000 do < 1/100), redki (≥ 1/10.000 do < 1/1.000), zelo redki (< 1/10.000) ter ni znano (ni mogoče oceniti na podlagi podatkov, ki so na voljo).
Don't use Trelegy Ellipta if you already use these medicines. 
Ne uporabljajte zdravila Trelegy Ellipta, če že uporabljate ta zdravila.
The patient should be assessed and alternative therapy instituted if necessary. 
Bolnika je treba oceniti in uvesti drugo zdravljenje, če je potrebno.
If your breathing or wheezing gets worse straight after using this medicine, stop using it and get medical help immediately. 
Če se vam dihanje ali piskanje takoj po uporabi tega zdravila poslabša, zdravilo nehajte uporabljati in takoj poiščite zdravniško pomoč.
See ‘Step-by-step instructions' in this leaflet for full information. 
Za celotne informacije glejte "Navodila po korakih" v tem navodilu.
Administration of Trelegy Ellipta to pregnant women should only be considered if the expected benefit to the mother justifies the potential risk to the foetus. 
Uporaba zdravila Trelegy Ellipta pri nosečnicah pride v poštev le, če pričakovana korist za mater upravičuje morebitno tveganje za plod.
What is the inhaler? 
Kaj je inhalator?
• pain in the back of the mouth and throat 
• bolečine v zadnjem delu ust in v grlu,
If your COPD symptoms (breathlessness, wheezing, cough) do not improve or get worse, or if you are using your quick-acting inhaler more often: 
Če se vam simptomi KOPB (težko dihanje, piskajoče dihanje, kašelj) ne izboljšajo ali se poslabšajo, ali če pogosteje uporabljate vaš hitrodelujoč inhalator,
Hypersensitivity to the active substances or to any of the excipients listed in section 6.1. 
Preobčutljivost za zdravilne učinkovine ali katero koli pomožno snov, navedeno v poglavju 6.1.
Trelegy Ellipta should be used every day and not only when you have breathing problems or other symptoms of COPD. 
Zdravilo Trelegy Ellipta morate uporabljati vsak dan in ne samo, kadar imate težave z dihanjem ali druge simptome KOPB.
Vilanterol (as alpha-phenylcinnamate) and triphenylacetic acid were not genotoxic indicating that vilanterol (as trifenatate) does not represent a genotoxic hazard to humans. 
Vilanterol (kot alfa-fenilcinamat) in trifenilocetna kislina nista bila genotoksična; to kaže, da vilanterol (kot trifenatat) ne pomeni genotoksične nevarnosti za človeka.
Stop using this medicine and seek medical help immediately, as you may have a serious condition called paradoxical bronchospasm. 
Nemudoma nehajte uporabljati to zdravilo in nemudoma poiščite zdravniško pomoč, ker gre lahko za resno stanje, imenovano paradoksni bronhospazem.
How to use the inhaler 
Kako uporabiti inhalator
Tell your doctor or pharmacist if you are taking any of these. 
Zdravniku ali farmacevtu morate povedati, če jemljete katero od teh zdravil.
Detailed information on this medicinal product is available on the website of the European Medicines Agency http://www.ema.europa.eu. 
Podrobne informacije o zdravilu so objavljene na spletni strani Evropske agencije za zdravila http://www.ema.europa.eu .
If you use too much of this medicine, contact your doctor or pharmacist for advice immediately as you may need medical attention. 
Če ste uporabili preveč tega zdravila, se takoj posvetujte z zdravnikom ali farmacevtom, ker boste morda potrebovali zdravniško pomoč.
Covariate analysis showed higher FF apparent clearance (42%) when comparing FF/VI to FF/UMEC/VI; however, this is not considered clinically relevant. 
Kovariatna analiza je pokazala višji navidezni očistek FF (42 %) v primerjavi FF/VI s FF/UMEC/VI, vendar se ti podatki ne smatrajo za klinično relevantne.
Don't use this medicine after the expiry date which is stated on the carton, tray and inhaler after ‘EXP'. 
Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na škatli, embalaži in inhalatorju poleg oznake "EXP".
Some medicines may affect how this medicine works, or make it more likely that you'll have side effects. 
Nekatera zdravila lahko vplivajo na delovanje tega zdravila ali povečajo verjetnost za pojav neželenih učinkov.